Urinary Tract Infection (UTI) is inflammation of the urinary tract system after microbial infection. Some of the symptoms of UTI include fever, dysuria, and lower abdominal pain, and the disease could be a community-acquired or nosocomial disease that affects patients after admission [1].

Urinary tract infection is a common bacterial infection that distresses human health. Reports show a yearly incidence of 150 million cases each year worldwide. In 2007, United States reported 10.5 million patient complaints of UTI symptoms and 2 - 3 million emergency admissions [2].

Different bacteria cause UTIs, but Gram-negative bacteria is the highest pathogen identified in urinary tract infections, more specifically, Escherichia coli shows 75% of urinary tract infections [3].

A troublesome issue is that antibiotics used for the management of urinary tract infections are getting weak, and sometimes it gets difficult to treat urinary tract infections [2].

Research conducted in India revealed that there was a statistically significant increase in the prevalence of antibiotic resistance of isolated uropathogenic organisms from 2009 to 2014. There was an increase in the resistance to Ampicillin (from 40.2% to 58.7%), Amoxiclav (from 26.2% to 40.5%), Nitrofurantoin (from 28.8% to 39.0%), and Norfloxacin (from 30% to 41.4%) and the highest cotrimoxazole from 35.5% in 2009 to 63.3% in 2014 [4].

Another research conducted in Kenya has shown an increase in antibiotic resistance that E. coli and K. pneumonia have shown poor susceptibility to Penicillins (8% - 48%), Cephalosporins of (16% - 43%), monobactams (17% - 29%), fluoroquinolones (22% - 44%) and trimethoprim-sulfamethoxazole (7%) [5].

In Somalia, research conducted in Mogadishu has exposed resistance of E. coli to antibiotics of cephalosporin such as Ceftriaxone 97% and Cefixime 61%. This shows that ceftriaxone does not give any results against the bacteria [6].

Conducting research on antibiotic resistance of uropathogenic E. coli in Somaliland will provide very important evidence that will enforce patient treatment guidelines and policies (Table 1).

The chapter discusses the methodology of research on uropathogenic E. coli resistance to antibiotics, the study targets patients of Hargeisa Group Hospital.

The study registered 98 participants for the research of antibiotic resistance of uropathogenic E. coli. As Table 2 shows the ages of participants were from 15 to 80 years that have been grouped into four age groups. Ages of group one were older than 50 years (29.6%), ages of group two were between 15 to 25 years old (27.6%), group three aged between 26 to 35 years old (22.4%), group four aged between 36 to 50 years old (22.4%).

Table 2 The age group of participants that starts at 15 to 80 years has been grouped into four groups.

Table 3 explains gender differences among interviewees; females were the majority of the research, 72.4% of interviewees while male participants were 27.6%.

The study revealed that 61.2% of the research participants have symptoms of urinary tract infection while 38.8% of participants have no symptoms of urinary tract infection. 49% of the respondents have a previous UTI and 51% percent of the respondents have no previous UTI.

As the data revealed 58% of the participants have negative results from UTIs while 42% have positive results. The study found that organisms that resulted in the infection were Escherichia coli (55%), Klebsiella spp (15%) Candida spp (15%) Enterococcus spp (10%), Staph spp (2.5%), and Pseudomonas spp (2.5%).

Figure 1 indicates the resistance of E. coli to certain antibiotics which are Tetracycline, Ampicillin and Cotrimoxazole. The worst case is Tetracycline which showed 70% resistance, Ampicillin exhibited 64% and Cotrimoxazole 61%. Ceftriaxone, Nalidixic acid, and Ciprofloxacin successively showed 43.5%, 43%, and 36%. E. coli showed the lowest resistance against Levofloxacin, Gentamicin, and Nitrofurantoin with a level of 23%, 17%, and 4%. Amikacin is the only antibiotic that E. coli did not give any resistance to it.

Figure 2 Explains that Amikacin and Nitrofurantoin performed wonderful activity against E. coli. The bacteria were extremely sensitive to the above-mentioned antibiotics with 100% and 96%. Levofloxacin and Gentamicin demonstrated lesser sensitivity than amikacin and Nitrofurantoin which were 73% and 74% respectively. E. coli developed approximately 50% sensitivity against ceftriaxone and Nalidixic acid. Cotrixamazole, Tetracycline, and Ampicillin antibiotics reported 39%, 27%, and 26% successively. The last three antibiotics displayed very poor performance against E. coli.

Identifying the antibiotic resistance pattern of uropathogenic E. coli is crucial for the health of society since UTI is common morbidity in Somaliland [9]. This study focused on identifying common bacteria that cause UTI and their patterns of antibiotic susceptibilities. The study recruited 98 participants who were tested for bacteria causing urinary tract infection and antibiotic resistance to uropathogenic E. coli. As the data revealed 58% of the participants had negative results of UTI while 42% had positive results. This showed a lower UTI rate in Hargeisa society in comparison to the research conducted in Mogadishu that reported 67% of UTI cases [10].

Participants in the study were aged 15 - 80 years and divided into four age groups. Based on respondent data analysis, the largest research participants fall into the over-50 (>50) age group, which accounts for 29.6% of respondents. The second largest group in the ranking was the age group 15 to 25, which was 27.6%. The 36 to 50 age group was 22.4% and the 26 to 35 age group had the lowest percentage, 20.4% of the total respondents.

Gender differences of the data respondents revealed that females were the majority of participants in the research which was 72.4% while male participants were 27.6%. Analysis of results reported that female participants showed a higher UTI rate of 58% (26/45) than male 48% (13/27).

The study revealed that 61.2% of the research participants have symptoms of urinary tract infection while 38.8% of participants have no symptoms of urinary tract infection at the time of visiting doctors therefore symptoms were relevant to the presence of UTI.

Participants of the research that have a previous UTI before examination were 49%, while 51% percent of the respondents have no previous infection. People with previous UTIs exhibited a resistance level of 1.6 times higher than people with no previous UTIs. This proves that recurrent UTIs increase the risk of MDR.

Organisms isolated from participants were Escherichia coli (55%), Klebsiella spp (15.0%), Candida spp (15%), Enterococcus spp (10%), Staph spp (2.5%) and Pseudomonas spp (2.5%). The results of the research matched with Lee H.S. et al. and Vasuevan, R. research [11] [12]. 55% of respondents did not give any bacterial growth.

The study demonstrated a high degree of resistance to E. coli against Tetracycline antibiotics, which was 70%, thus similar to findings of Kibret, M. and Abera, B. research in Ethiopia [13].

On the other hand, the study observed that ampicillin and cotrimoxazole showed resistance levels against E. coli of 64% and 61% respectively. Other studies have indicated higher E. coli resistance to ampicillin and cotrimoxazole at 94.8% and 85.1% respectively [14]. Mohamoud, H. presented his research in Hargeisa that E. coli resistance to ampicillin is 50% [9], which was consistent with this study.

Ceftriaxone, Nalidixic acid, and Ciprofloxacin accounted for 43.5%, 43%, and 36% respectively. The rate of resistance of E. coli to ciprofloxacin was almost the same in association with the Mogadishu study which indicated 37.2% [6]. E. coli resistance to ceftriaxone (43.5%) is not at an alarming level compared to the findings of researchers in Mogadishu, which represented 97.1% and 80.6% respectively [12] [13] so, timely decisions are required to manage the use of this antibiotic in society. Nalidixic acid reaction against the bacteria showed 43%, this shows very near to the findings of other researchers [15].

Amikacin, Nitrofurantoin, Levofloxacin, and Gentamicin performed well in the control of uropathogenic E. coli. The bacteria were exceptionally sensitive to these antibiotics with a rate of 100% and 96%, 73%, and 74% respectively. Mohamed, A.H. et al. [14] reported an amikacin E. coli susceptibility of 93.2%, nitrofurantoin 91.6%, levofloxacin 37.5%, and gentamicin 61.3%. The results of the research carried out by Mohamed, A.H. et al. agree with this study except for levofloxacin, which gives lower reaction activity (Table 4).

The overall incidence of antibiotic resistance to E. coli is high because the bacteria showed a percentage of resistance to each antibiotic except Amikacin which gives (100%) sensitivity. The study recommends further research on the topic to identify the major factors that cause antibiotic resistance.

The study finally gives these recommendations:

· The Ministry of Health should develop awareness programs to teach society about the risk of antibiotic overuse. Programs should also emphasize the importance of clinicians’ prescriptions and over-the-counter antibiotic problems.

· Health care institutions should develop treatment guidelines to find a clear route of patient treatment.

· Clinicians are encouraged to request a bacterial culture and antibiotic susceptibility test prior to treatment if they suspect a relapse of infection or antibiotic resistance.

· Research recommends further research in this area, such as identifying strains of E. coli that are more resistant.

This work would not have been feasible without my advisors, Dr. Helmi and Nadira Hariir, for their ongoing support, direction, and assistance. Their levels of patience, knowledge, and ingenuity are something I will always admire. I want to express my appreciation to my wife, Nimco Ahmed, for her continued support and encouragement throughout my career. Finally, I want to thank the director of Hargeisa Group Hospital for accepting this hospital-based research.

The authors declare no conflicts of interest regarding the publication of this paper.

Abdi, H.M., Hassan, M.I., Abdulaziz, H.E. and Omer, N.H. (2022) Antiboitic Resistance of Uropathogenic Eshcherichia coli in Pateints of Hargeisa Group Hospital, Hargeisa, Somaliand. Advances in Microbiology, 12, 333-342. https://doi.org/10.4236/aim.2022.125024